- Products & Solutions
- Access choices
- Application performance management
- Internet services
- IP address management
- Managed network services
- Virtual Private Network Services
- Network services solutions
- Business technology services
- CRM professional services
- IT professional services
- Mobility professional services
- Network professional services
- Unified communications professional services
- Identity and Access Management
- Managed security services
- Security Consulting
- Security Intelligence
- Security solutions
- Cloud contact centers
- Contact recording and analytics
- Inbound services
- Onsite contact centres
- Self-service and queue-management platforms
- CRM solutions
- Why BT
Our position and recognition in published analyst reports.
We believe in the power of communication to make a better world
We are proud that our work is recognized time and again by customers, analysts and professional organizations
Our company overview: how we're bringing it all together around the world
Who we’ve helped, and how. Learn how organizations just like yours get better when they work with us.
Join us to explore fresh ideas
Explore and debate the big issues with us as we bring together the latest insight on the hottest IT trends.
From press releases to local news
Great thinking from across the company
Our range of showcases offers you an online or face-to-face insight into our portfolio and its capabilities.
- Let's Talk
- My Account
Press release: BT and Exostar to help life sciences organizations collaborate securely and productively
DC14-187 (29 April 2014)
Scientists engaged in collaborative initiatives can now securely access Transformative Cloud-based solution
BT and Exostar, LLC announced today that Exostar is joining the BT for Life Sciences ecosystem as a Strategic Member. The two companies will be working closely together to enable Exostar’s federated identity solutions to ensure life sciences organizations receive seamless, secure access to the BT for Life Sciences cloud compute platform.
Health datasets are increasingly used in drug development, clinical trials and health analytics. In addition, new legislation means that pharmaceutical companies need to give stakeholder access to clinical trials data, which are often sensitive. BT for Life Sciences has already launched solutions which provide scientists easy and effective access to the rich sources of information, based on its innovative cloud-based infrastructure. These are available today on a global basis.
The next step in the BT for Life Sciences evolution brings a leading industry-standard method of securing access to these solutions and associated information, enabling a secure ecosystem approach to life sciences collaboration. To take that next step, BT for Life Sciences is teaming with Exostar, a leading provider of cloud-based identity and access management solutions for the life sciences industry. Ecosystem users may be ‘in-house’ employees, come from collaborative organizations involved in drug research and development, or from other agencies such as regulators.
BT and Exostar aim to deliver a joint proposition that leverages their respective capabilities to address the secure, federated collaboration challenges of the life sciences market. Exostar will be providing their cloud-based identity and access management solution suite, anchored by the Exostar Life Sciences Identity Hub. Organizations connect once to the Identity Hub, which provides them with trusted pathways to the assets of all of their partners in the community, and vice versa. Individuals benefit from a single sign-on user experience that allows them to use one credential to access the applications and information they need to collaborate productively and securely.
The combination of BT for Life Sciences, the BT Cloud Compute platform, and Exostar’s Life Sciences Identity Hub aims to permit easy, rapid and safe access to existing solutions. It will also enable the future development of virtual ‘scientist workbenches’ tailored to various disciplines such as Bioinformatics and Cheminformatics. The mutual goal of both companies is to let the scientist focus on the science and not have to worry about the complexities of secure information management, particularly in a cloud environment that crosses enterprise boundaries.
“BT and Exostar have complementary service offerings whose combination delivers exceptional value to life sciences organizations,” said Vijay Takanti, Exostar’s Vice President of Security and Collaboration. “The pairing of BT’s global life sciences solution platform with Exostar’s expertise in deploying cloud-based federated identity solutions to the life sciences community is a force multiplier that will accelerate time-to-market for life-saving drugs, therapies, and treatments that save lives.”
Yury Rozenman, Business Development Director, BT for Life Sciences, said, “Building on the launch of BT for Life Sciences in 2012, we are excited that our collaboration with Exostar is bringing new innovations to the Life Sciences industry. By making it easier for scientists to collaborate securely when working with sensitive data and systems, we can help to enable transformative approaches to healthcare. Working together, BT and Exostar are giving scientists efficient and cost-effective access to truly empowering technologies, whilst respecting the security and confidentiality challenges that they face.”
BT is one of the world’s leading providers of communications services and solutions, serving customers in more than 170 countries. Its principal activities include the provision of networked IT services globally; local, national and international telecommunications services to its customers for use at home, at work and on the move; broadband, TV and internet products and services; and converged fixed/mobile products and services.BT consists principally of five lines of business: BT Global Services, BT Business, BT Consumer, BT Wholesale and Openreach.
For the year ended 31 March 2013, BT Group’s reported revenue was £18,103m with reported profit before taxation of £2,315m.
British Telecommunications plc (BT) is a wholly-owned subsidiary of BT Group plc and encompasses virtually all businesses and assets of the BT Group.BT Group plc is listed on stock exchanges in London and New York.
For more information, visit http://www.btplc.com/.
Exostar powers secure business-to-business information sharing, collaboration and business process integration throughout the value chain. Exostar supports the complex trading needs of many of the world's largest companies in aerospace and defense, life sciences, and other industries. Exostar’s cloud-based identity assurance products and business applications reduce risk, improve agility and strengthen trading partner relationships and profitability for over 100,000 companies in 150 countries worldwide. The Exostar community includes market leaders such as AstraZeneca, BAE Systems, Bell Helicopter, The Boeing Company, BT, Computer Sciences Corporation, Lockheed Martin Corp., Merck, Newport News Shipbuilding, Northrop Grumman, Raytheon Co. and Rolls-Royce. For more information, please visit http://www.exostar.com/.
For further information:
Please contact Alan Ball, Head of Global PR.